FRESENIUS MEDICAL CARE AG (1FME.MI) Stock Fundamental Analysis
Europe - BIT:1FME - DE0005785802 - Common Stock
41.89 EUR
+1.05 (+2.57%)
1FME gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 30 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of 1FME get a neutral evaluation. Nothing too spectacular is happening here. 1FME is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
1FME had positive earnings in the past year.
In the past year 1FME had a positive cash flow from operations.
In the past 5 years 1FME has always been profitable.
Each year in the past 5 years 1FME had a positive operating cash flow.
1.2 Ratios
1FME has a Return On Assets of 2.10%. This is comparable to the rest of the industry: 1FME outperforms 46.67% of its industry peers.
1FME has a Return On Equity of 4.95%. This is in the lower half of the industry: 1FME underperforms 60.00% of its industry peers.
The Return On Invested Capital of 1FME (3.84%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for 1FME is below the industry average of 6.66%.
The 3 year average ROIC (3.14%) for 1FME is below the current ROIC(3.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.1% | ||
| ROE | 4.95% | ||
| ROIC | 3.84% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
Looking at the Profit Margin, with a value of 3.36%, 1FME is in the better half of the industry, outperforming 63.33% of the companies in the same industry.
1FME's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 7.15%, 1FME perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
1FME's Operating Margin has declined in the last couple of years.
1FME has a Gross Margin (24.67%) which is comparable to the rest of the industry.
1FME's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.15% | ||
| PM (TTM) | 3.36% | ||
| GM | 24.67% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1FME is destroying value.
1FME has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1FME has less shares outstanding
1FME has a better debt/assets ratio than last year.
2.2 Solvency
1FME has an Altman-Z score of 2.19. This is not the best score and indicates that 1FME is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.19, 1FME is in line with its industry, outperforming 56.67% of the companies in the same industry.
The Debt to FCF ratio of 1FME is 5.47, which is a neutral value as it means it would take 1FME, 5.47 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 5.47, 1FME is doing good in the industry, outperforming 76.67% of the companies in the same industry.
1FME has a Debt/Equity ratio of 0.71. This is a neutral value indicating 1FME is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.71, 1FME is doing good in the industry, outperforming 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.47 | ||
| Altman-Z | 2.19 |
ROIC/WACC0.67
WACC5.74%
2.3 Liquidity
A Current Ratio of 1.44 indicates that 1FME should not have too much problems paying its short term obligations.
1FME has a Current ratio of 1.44. This is in the better half of the industry: 1FME outperforms 66.67% of its industry peers.
1FME has a Quick Ratio of 1.08. This is a normal value and indicates that 1FME is financially healthy and should not expect problems in meeting its short term obligations.
1FME has a Quick ratio of 1.08. This is in the better half of the industry: 1FME outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
1FME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.51%, which is quite good.
The Earnings Per Share has been decreasing by -6.43% on average over the past years.
Looking at the last year, 1FME shows a small growth in Revenue. The Revenue has grown by 0.53% in the last year.
The Revenue has been growing slightly by 2.04% on average over the past years.
EPS 1Y (TTM)17.51%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.29%
Revenue 1Y (TTM)0.53%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%0.55%
3.2 Future
1FME is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.32% yearly.
1FME is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.75% yearly.
EPS Next Y14.02%
EPS Next 2Y12.14%
EPS Next 3Y13.1%
EPS Next 5Y13.32%
Revenue Next Year1.83%
Revenue Next 2Y2.62%
Revenue Next 3Y3.09%
Revenue Next 5Y3.75%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 12.00, the valuation of 1FME can be described as correct.
Based on the Price/Earnings ratio, 1FME is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.28, 1FME is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 10.25, the valuation of 1FME can be described as reasonable.
Based on the Price/Forward Earnings ratio, 1FME is valued a bit cheaper than 80.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of 1FME to the average of the S&P500 Index (33.61), we can say 1FME is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12 | ||
| Fwd PE | 10.25 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1FME indicates a slightly more expensive valuation: 1FME is more expensive than 60.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1FME indicates a somewhat cheap valuation: 1FME is cheaper than 63.33% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.2 | ||
| EV/EBITDA | 10.94 |
4.3 Compensation for Growth
1FME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as 1FME's earnings are expected to grow with 13.10% in the coming years.
PEG (NY)0.86
PEG (5Y)N/A
EPS Next 2Y12.14%
EPS Next 3Y13.1%
5. Dividend
5.1 Amount
1FME has a Yearly Dividend Yield of 3.38%. Purely for dividend investing, there may be better candidates out there.
1FME's Dividend Yield is rather good when compared to the industry average which is at 2.55. 1FME pays more dividend than 90.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, 1FME pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.38% |
5.2 History
The dividend of 1FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1FME pays out 64.37% of its income as dividend. This is not a sustainable payout ratio.
The dividend of 1FME is growing, but earnings are growing more, so the dividend growth is sustainable.
DP64.37%
EPS Next 2Y12.14%
EPS Next 3Y13.1%
BIT:1FME (11/5/2025, 7:00:00 PM)
41.89
+1.05 (+2.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners37.52%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap24.58B
Revenue(TTM)19.52B
Net Income(TTM)656.42M
Analysts65.6
Price Target51.99 (24.11%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.38% |
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP64.37%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.41%
Min EPS beat(2)18.67%
Max EPS beat(2)24.14%
EPS beat(4)4
Avg EPS beat(4)20.91%
Min EPS beat(4)15.03%
Max EPS beat(4)25.81%
EPS beat(8)7
Avg EPS beat(8)15.87%
EPS beat(12)10
Avg EPS beat(12)13.98%
EPS beat(16)12
Avg EPS beat(16)10.16%
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)2.74%
Revenue beat(4)2
Avg Revenue beat(4)0.26%
Min Revenue beat(4)-4.4%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.44%
Revenue beat(12)5
Avg Revenue beat(12)-0.49%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)9.52%
PT rev (3m)9.52%
EPS NQ rev (1m)69.06%
EPS NQ rev (3m)69.06%
EPS NY rev (1m)-0.65%
EPS NY rev (3m)-0.65%
Revenue NQ rev (1m)-5.76%
Revenue NQ rev (3m)-5.76%
Revenue NY rev (1m)-2.55%
Revenue NY rev (3m)-2.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12 | ||
| Fwd PE | 10.25 | ||
| P/S | 1.26 | ||
| P/FCF | 12.2 | ||
| P/OCF | 8.93 | ||
| P/B | 1.85 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.94 |
EPS(TTM)3.49
EY8.33%
EPS(NY)4.09
Fwd EY9.76%
FCF(TTM)3.43
FCFY8.2%
OCF(TTM)4.69
OCFY11.2%
SpS33.26
BVpS22.61
TBVpS-2.73
PEG (NY)0.86
PEG (5Y)N/A
Graham Number42.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.1% | ||
| ROE | 4.95% | ||
| ROCE | 5.44% | ||
| ROIC | 3.84% | ||
| ROICexc | 4.19% | ||
| ROICexgc | 11.45% | ||
| OM | 7.15% | ||
| PM (TTM) | 3.36% | ||
| GM | 24.67% | ||
| FCFM | 10.32% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score6
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.47 | ||
| Debt/EBITDA | 3.14 | ||
| Cap/Depr | 45.83% | ||
| Cap/Sales | 3.79% | ||
| Interest Coverage | 3.82 | ||
| Cash Conversion | 91.56% | ||
| Profit Quality | 307% | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | 2.19 |
F-Score6
WACC5.74%
ROIC/WACC0.67
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)17.51%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.29%
EPS Next Y14.02%
EPS Next 2Y12.14%
EPS Next 3Y13.1%
EPS Next 5Y13.32%
Revenue 1Y (TTM)0.53%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%0.55%
Revenue Next Year1.83%
Revenue Next 2Y2.62%
Revenue Next 3Y3.09%
Revenue Next 5Y3.75%
EBIT growth 1Y2.71%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year100.38%
EBIT Next 3Y31.03%
EBIT Next 5Y18.99%
FCF growth 1Y14.07%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y14.41%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE AG / 1FME.MI FAQ
What is the fundamental rating for 1FME stock?
ChartMill assigns a fundamental rating of 5 / 10 to 1FME.MI.
What is the valuation status of FRESENIUS MEDICAL CARE AG (1FME.MI) stock?
ChartMill assigns a valuation rating of 6 / 10 to FRESENIUS MEDICAL CARE AG (1FME.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for FRESENIUS MEDICAL CARE AG?
FRESENIUS MEDICAL CARE AG (1FME.MI) has a profitability rating of 4 / 10.
What are the PE and PB ratios of FRESENIUS MEDICAL CARE AG (1FME.MI) stock?
The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (1FME.MI) is 12 and the Price/Book (PB) ratio is 1.85.
Is the dividend of FRESENIUS MEDICAL CARE AG sustainable?
The dividend rating of FRESENIUS MEDICAL CARE AG (1FME.MI) is 6 / 10 and the dividend payout ratio is 64.37%.